Event Title Go back to Home Page
Event Summary  
Event Type Medicine - Pharmaceutical Recalls  Date Time 2019-10-22 20:06:00 
Country US  City Hyderabad, TS 
Latitude 17.441  Longitude 78.474 
URL businesswire.com/news/home/20191023005314/en/     
[businesswire.com] INDIA - Dr Reddys Confirms Its Voluntary Nationwide Recall Of All Ranitidine Products In The US Market

"Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries, together referred to as “Dr. Reddy’s”) confirms it had initiated a voluntary nationwide recall on October 1, 2019, (at the retail level for over-the-counter products and at the consumer level for prescription products) of all of its ranitidine medications sold in US due to confirmed contamination with N-Nitrosodimethylamine (NDMA) above levels established by the FDA."

Read the full article:



Copyright © 2006-2012  All Rights Reserved.